Additionally, our results indicate that within the ACC cohort, GABRD expression is upregulated in a subset of patient tumors with lower ABAT transcript levels, and that GABRD upregulation is not only unfavorably prognostic, but also may be associated with a decreased capacity to degrade GABA. The gene discussed is ABAT; the disease is adrenal cortex carcinoma.